Cue Biopharma CUE
NASDAQ CUE
$18.95 +1.91 (+11.21%)
At close: Oct 21, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Share-based Compensation (2017 - 2026)

Updated

Cue Biopharma (CUE) reported Share-based Compensation of $610,000 for Q4 2025, down 60.9% from $1.56 million a year earlier and down 60.2% from the prior quarter.

Analysis

Cue Biopharma (CUE) Share-based Compensation (2017 - 2026) Analysis & Trends

For FY2025, Cue Biopharma posted Share-based Compensation of $4.74 million, down 30.7% from FY2024.

  • Share-based Compensation has declined for four consecutive years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
  • By year, Share-based Compensation came in at $6.85 million in FY2024 (-16.3%), $8.18 million in FY2023 (-13.9%), $9.5 million in FY2022 (-17.5%) and $11.52 million in FY2021 (+9.9%).
  • The Q4 2025 figure ranks as the lowest quarterly Share-based Compensation since Q1 2017.
  • Year over year, Share-based Compensation has now declined in each of the last nine quarters, with an average decline of 23.5% over the last eight quarters.
  • The high point for year-over-year Share-based Compensation in five years was Q4 2021 (growth of 30.4%); the low point was Q4 2025 (a decline of 60.9%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $1.53 million (Q3 2025), $1.26 million (Q2 2025) and $1.34 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 Cue Biopharma 121.14 Mn 30.41 Mn - 23.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.84 Mn
Dec 31, 2025 610,000.00
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 1.34 Mn
Dec 31, 2024 1.56 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2024 1.76 Mn
Mar 31, 2024 1.95 Mn
Dec 31, 2023 2.07 Mn
Sep 30, 2023 2.07 Mn
Jun 30, 2023 2.04 Mn
Mar 31, 2023 2.00 Mn
Dec 31, 2022 2.11 Mn
Sep 30, 2022 2.06 Mn
Jun 30, 2022 2.31 Mn
Mar 31, 2022 3.01 Mn
Dec 31, 2021 2.97 Mn
Sep 30, 2021 3.25 Mn
Jun 30, 2021 2.85 Mn
API Access

Cue Biopharma Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CUE&period=max&api_key=YOUR_API_KEY